Background-There is a reported association between high clinical volume and improved outcomes. Whether this relationship is true for outpatients with coronary artery disease (CAD), heart failure (HF), and atrial fibrillation (AF) remains unknown. Methods and Results-Using the PINNACLE Registry (2009)(2010)(2011)(2012), average monthly provider and practice volumes were calculated for CAD, HF, and AF. Adherence with 4 American Heart Association CAD, 2 HF, and 1 AF performance measure were assessed at the most recent encounter for each patient. Hierarchical logistic regression models were used to assess the relationship between provider and practice volume and performance on eligible quality measures. Data incorporated patients from 1094 providers at 71 practices (practice level analyses n=654 535; provider level analyses n=529 938). Median monthly provider volumes were 79 (interquartile range [IQR], 51-117) for CAD, 27 (16-45) for HF, and 37 (24-54) for AF. Median monthly practice volumes were 923 (IQR, 476-1455) for CAD, 311 (145-657) for HF, and 459 (185-720) for AF. Overall, 55% of patients met all CAD measures, 72% met all HF measures, and 58% met the AF measure. There was no definite relationship between practice volume and concordance for CAD, AF, or HF (P=0.56, 0.52, and 0.79, respectively). In contrast, higher provider volume was associated with increased concordance for CAD and AF performance measures (P<0.001 for both), but not for HF (P=0.36). Conclusions-In the PINNACLE registry, performance was modest and variable. Higher provider volume was positively associated with quality, whereas practice volume was not. (Circ Cardiovasc Qual Outcomes. 2016;9:48-54.
P erformance measures that improve patient outcomes for common cardiac conditions exist for both inpatient and outpatient care; however, most of the literature addresses guideline concordance in the inpatient setting. The PINNACLE registry was developed as a quality improvement tool for cardiology practices in the outpatient setting. Previous work with the registry demonstrates variable performance on individual quality metrics ranging from very low (13% screening for diabetes mellitus in patients with coronary artery disease [CAD]) to very high (97% blood pressure measurements in patients with heart failure [HF]). 1 To improve patient outcomes, it is important to better understand the factors that influence guideline concordance in outpatient practice.
Physician-and practice-level patient volume may be associated with better performance and higher quality of care. In the surgical literature, higher physician and, to a lesser extent, hospital procedural volumes correlate with lower mortality rates. [2] [3] [4] For nonsurgical specialties, there are much less robust data; however, smaller hospitals may provide lower quality care for patients with HF as measured by guideline concordance. 5 Similar data from the outpatient setting are much more limited. Studies from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting have shown a positive association between the number of physicians per practice and referral rates for implantable cardiac defibrillator implantation. 6, 7 To our knowledge, no study has examined the relationship between patient volume at the physician and practice levels and guideline concordance for CAD, HF, and atrial fibrillation (AF) in the outpatient setting. Practice characteristics such as the availability of support staff (eg, medical assistants and nursing staff), ancillary providers (eg, advanced practice nurses, physician assistants, and dieticians), the existence of advanced electronic medical record features (eg, prompts and reminders), and the existence of established treatment protocols are likely to vary with practice size and may influence guideline concordance. We hypothesized that higher patient volume at the provider and practice level is associated with greater quality of care as measured by concordance with published performance measures.
Methods

Study Population
Our study population consisted of CAD, HF, and AF patients aged ≥18 years in the PINNACLE registry between 2009 and 2012. Launched in 2008, PINNACLE is the first outpatient-based prospective quality improvement registry, including patients from cardiology practices across the United States. Data collected includes patient demographics, medical history, vital signs, laboratory values, imaging results, medications, and contraindications to medications. Data are extracted directly from the practices' electronic medical records or via a paper-based reporting form. Data collection is standardized using established definitions, uniform data entry and transmission, and quality checks. 1 In addition, rigorous back-end data quality checks are performed on the extracted data, and any data not meeting predefined quality thresholds are quarantined from analyses and flagged for manual review and follow-up with individual practices.
Using the most recent 12 months of data for each participating practice, we assessed performance for a given patient at their most recent encounter. For provider-level analyses, we excluded nonphysician providers and excluded patients who saw >1 provider during the study period because this would make it difficult to attribute performance to individual providers. This gave us a patient population of 529 938. Practices with <6 months of data were excluded. This gave us a patient population of 654 535. For each practice, monthly volumes (total encounters) were tallied for the most recent 12 calendar months of data, excluding the first and last calendar months to account for practices that may have started or stopped submitting data in the middle of a month. Average monthly volumes were then calculated for each provider and each practice.
Performance Measures Calculations
Medication-related performance measures for each patient with CAD, HF, and AF were evaluated, using standard American Heart Association definitions, among eligible patients with no exclusions or contraindications for each cardiac condition. We used data from the most recent encounter for each patient. The measures for CAD included (1) β-blocker therapy after myocardial infarction, (2) antiplatelet therapy, (3) angiotensin-converting enzyme inhibitor (ACEI)/ angiotensin II receptor blocker (ARB) therapy, and (4) lipid-lowering therapy. 8 For HF, the performance measures included β-blocker therapy for patients with an ejection fraction <40% and ACEI/ARB therapy for patients with an ejection fraction <40%. 9 For AF, anticoagulant therapy for patients with a CHADS2 score (congestive heart failure, hypertension, age=75 years, diabetes mellitus, and stroke) of ≥2 was the only performance measure. 10, 11 For each disease condition, the primary outcome was 100% performance for all eligible measures for each patient and reported as a summary performance measure.
Statistical Analysis
Patient, provider, and practice characteristics were summarized with descriptive statistics. The relationship between provider and practice volume on the summary measure of performance (100% performance for every measure) as well as individual measures was assessed using hierarchical logistic regression models. The physician-level model included a random effect for practice, a fixed effect for monthly physician volume, and random effects for physician and physician volume nested within practice. The practice-level model included a random effect for practices and a fixed effect for monthly practice volume. Volume was assessed as a continuous variable with restricted cubic splines to accommodate for nonlinear associations. The associations with patient volume were also summarized by volume tertiles to facilitate interpretation. These models were additionally adjusted for geographic region.
Because the physician-level analyses were conducted on a subset of patients (those seen by only 1 physician provider), we conducted a secondary analysis on this subset using inverse probability weighting to reweight the subset to reflect the distribution of patient characteristics in the entire study sample. A logistic regression model was constructed estimating the probability of a patient seeing a single physician provider on the basis of their demographic and clinical characteristics. The physician-level analyses were then rerun weighting each patient by the inverse of their probability. In almost all cases, the results obtained from this analysis were nearly identical to those of the unweighted analysis and so are not presented, except as noted in the results below.
Finally, to determine whether the effects of volume were reflecting differences in the number of new versus established patients, we repeated all analyses with the study cohort restricted to only those patients with ≥2 visits with the same provider in the previous 12 months.
All analyses were evaluated at a 2-sided significance level of 0.05. Analyses were performed using SAS v9.4 for Windows (SAS Institute, Inc, Cary, NC) and R version 3.2.0. 12 The PINNACLE Registry has been reviewed and approved by the American College of Cardiology Foundation's contracted Institutional Review Board.
Results
During the study period, data were available for 654 535 patients, seen by 1094 providers at 71 practices; provider-level analyses included 529 938 patients seen by a single physician provider (930 providers at 70 practices). Overall, the mean age of patients was 68.5±13.3 years and 42.9% were female. The majority of patients (90.7%) were white and privately insured (60.0%). The most common comorbidities were hypertension (89.0%), hyperlipidemia (76.6%), previous myocardial infarction (33.4%), and diabetes mellitus (27.9%; Table 1 ).
WHAT IS KNOWN
• In the surgical literature, increased volume of patients improves performance measured by compliance with quality metrics.
WHAT THE STUDY ADDS
• This study evaluates for the first time the relationship between patient volume and performance in 3 common cardiac conditions. • Higher volume practices were not associated with better performance. • Providers with higher volumes of patients with coronary artery disease and atrial fibrillation had better adherence to performance measures. • Providers with higher volumes of patients with heart failure did not have a significantly different adherence rate.
Among all 1094 providers, 88% were physicians, 10% were advanced practice providers, and 2% were other providers ( Table 2 ). The 71 practices were located as follows: 26 (36.6%) in the South, 16 (22.5%) in the Midwest, 16 (22.5%) in the West, and 13 (18.3%) in the Northeast (Table 3 ).
Coronary Artery Disease
Overall, there were 529 124 patients with at least 1 encounter for CAD. The median practice volume was 923 CAD encounters per month (interquartile range [IQR], 476-1455), and among patients seeing a single physician provider, the median volume per provider was 79 CAD encounters per month (IQR, 51-117).
We assessed 4 medication-related CAD performance measures: prescription of an ACEI or ARB, a β-blocker, lipidlowering therapy, and antiplatelet agents. Overall, 55% of patients were prescribed all therapies for which they were eligible. Higher monthly provider volumes were associated with improved adherence to performance measures, with those in the highest tertile of provider volume being more likely to have their patients meeting 100% of eligible measures than those in the lowest tertile (adjusted odds ratio [OR], 1.14; 95% confidence interval [CI], 1.01-1.29; P<0.001 for overall association). Similar associations were found with adherence to antiplatelet therapy, ACEI/ARB therapy, and lipid-lowering therapy individually ( Figure 1 ). However, we found no significant association between monthly practice volume and adherence to individual medications (OR, Figure 1) ; however, the variability was high.
Heart Failure
Overall, there were 212 612 encounters for HF, and 26 658 (12.5%) of them were for patients with documented systolic dysfunction (left ventricular ejection fraction <40%). The median volume of patients with HF for each provider was 27 encounters per month (IQR, , and the median practice volume per month was 311 (IQR, 145-657). Overall Figure 2 ).
Atrial Fibrillation
There were a total of 157 283 patients with AF, and a CHADS2 11 score (congestive heart failure, hypertension, age=75 years, diabetes mellitus, and stroke) of ≥2 who were eligible for anticoagulant. The median volume of patients with AF seen by each provider per month was 37 (IQR, 24-54) and the median practice volume per month was 459 (IQR, 185-720). Guideline concordance rates were similar to CAD, with 58% of patients meeting the anticoagulation measure. Providers in the highest volume tertile of patients with AF were more likely to prescribe anticoagulant therapy in eligible patients with AF, relative to the lowest tertile (OR, 1.15 [95% CI, 1.07-1.25], P<0.001; Figure 3 ). Monthly practice volume was not associated with guideline concordance (OR, 1.12 [95% CI, 0.86-1.47], P=0.79).
Sensitivity Analysis
To assess whether the effects of volume might be related to the number of new versus established patients, we performed a sensitivity analysis restricted to only those patients seen more than once in a 12-month period by either a single provider or a practice. About two thirds of the total patient population had multiple encounters. The effects of volume were unchanged from our primary analysis. Practice volume was not associated with 100% concordance for CAD, AF, or HF performance measures (P=0.54, 0.59, and 0.72, respectively), whereas provider volume remained associated with increased concordance for CAD and AF performance measures (P=0.004 and <0.001, respectively). We also analyzed the effect of volume on concordance continuously using splines and found no difference in the findings (Appendix I in the Data Supplement).
Discussion
In recent years, cardiology practices have grown in size through mergers between smaller practices and through hospital acquisitions; these organizational changes hold promise to improve the quality of care through improved integration and coordination of care. In a national registry of outpatient cardiology patients, we examined the relationship between provider and practice volume and guideline concordance. We found that practice volume was not associated with concordance for CAD, AF, or HF although the CIs were wide and it is likely this variability reduced our ability to detect an association. In contrast, higher provider volume was associated with increased concordance for CAD and AF performance measures, but not for HF. To our knowledge, this is the first study examining the relationship between provider and practice volume and guideline concordance in outpatient practice. The surgical literature has described a robust relationship between procedural volume and outcomes. Patients undergoing coronary artery bypass grafting at high-volume hospitals have lower mortality rates than those treated at low-volume hospitals. For instance, an analysis of the New York State registry found that the risk-adjusted mortality rate for patients treated by surgeons doing >125 surgeries per year in hospitals seeing >600 cases per year was 1.89% versus 2.67% in lower volume centers with less active surgeons. 13 A further study also showed that this relationship holds regardless of the individual patient's overall preoperative risk. 14 The same relationship at both the provider and the hospital level has also borne out for percutaneous coronary interventions. 15 Some studies have demonstrated a relationship between volume and outcome for nonsurgical conditions, particularly ventilated patients in the intensive care unit. Kahn et al 16 found that higher volume hospitals (>300 admissions/yr) had lower 30-day mortality rates for nonsurgical ventilated patients in the intensive care unit, with an absolute risk reduction of 3.4%. They concluded that higher volume centers are more likely to adopt new and better treatment strategies such as early goaldirected therapy for sepsis and low tidal volume ventilation for acute respiratory distress syndrome and that these practices contribute to improved outcomes. In a study of Medicare administrative data, Ross et al 17 found an association between increasing hospital volumes and improved mortality rates for pneumonia, HF, and acute myocardial infarction.
With increasing integration of the healthcare system, it is critical to understand the relationship between volume and performance. Analyzing the Medicare claims database, Joynt et al 18 found that lower volume hospitals may perform worse for patients with HF than higher volume hospitals. Using Hospital Quality Alliance performance measures, they found that hospitals with the lowest volume of patients with HF performed worse than their high-volume counterparts (80.2% versus 89.15 concordance). Furthermore, they demonstrated that guideline concordance correlated with lower mortality.
Some authors have used this volume-outcome relationship to justify regionalization of both high-risk surgical care and intensive care. 19, 20 Others suggest that further research is needed to define the factors contributing to large hospitals' success so that these can be exported to lower volume centers. For example, 1 study performed in the Veterans Affairs Health System suggests that the effects of low volumes may be overcome through process standardization. The trial demonstrated equivalent 30-day mortality rates at low-volume facilities. 21 We postulated that the organization of outpatient practices may also differ by patient and provider volume and that this variation would affect performance on guideline concordance. For example, low-volume practices may lack resources to support ancillary services, advanced practice providers, and advanced electronic medical records and, therefore, standardized processes may be more efficiently applied to larger volume practices. At the other extreme, the highest volume practices may emphasize patient volume at the expense of quality. Nonetheless, we did not find an association between practice volume and concordance with performance measure adherences for 3 common cardiac conditions seen in the outpatient setting.
Provider volume, however, seems to be an important factor in guideline concordance. Our negative findings for HF may reflect the already high levels of concordance for this condition. However, for CAD and AF overall concordance remains low and targeting the factors that affect provider concordance will help to improve care. From our study, it seems that provider volume can improve concordance. This finding will be important to those developing new practice models. HF is now its own separate specialty and its higher rates of overall guideline concordance may reflect greater provider specialization, and therefore higher provider volumes, than conditions such as CAD and AF. Further work is needed to identify methods of incorporating best practices for lower volume providers so that they can attain similar performance.
Our findings must be evaluated in light of several limitations. The PINNACLE Registry includes detailed clinical data from a large real world cohort of patients nationwide. The data derive from practices that voluntarily participate in a quality improvement registry and may not be generalizable to all cardiology practices. The data are extracted from electronic medical records and documentation may be incomplete for some quality metrics, although medication data are reliably captured. Even so, it is possible that contraindications to individual therapies may have been incompletely captured. More than 80% of patients with HF had missing left ventricular ejection fraction data and these patients were excluded. PINNACLE Registry does not distinguish between missing data and no responses, which may bias results. In addition, we were unable to account for the organizational structure of practices in this study and could not assess whether ancillary services were available. Furthermore, >90% of the participants were white and 35% had missing race data, which may limit the applicability of the study. We were unable to control for patient case mix, which may have led to confounding. Finally, we are unable to assess provider specialty information within a given practice.
Conclusions
In a large contemporary population of cardiology patients, performance on published quality measures for CAD, HF, and AF was modest and variable. Higher provider volume was positively associated with adherence to performance measures for CAD and AF, but we could detect no association between practice volume and performance for any of these 3 cardiac conditions.
